Investigational Drug Information for ASP8062
What is the development status for investigational drug ASP8062?
ASP8062 is an investigational drug.
There have been 7 clinical trials for ASP8062.
The most recent clinical trial was a Phase 2 trial, which was initiated on October 8th 2021.
The most common disease conditions in clinical trials are Substance-Related Disorders, Opioid-Related Disorders, and Disease. The leading clinical trial sponsors are Astellas Pharma Global Development, Inc., Astellas Pharma Inc, and National Institute on Drug Abuse (NIDA).
There are two US patents protecting this investigational drug and thirty-four international patents.
Summary for ASP8062
| US Patents | 2 |
| International Patents | 34 |
| US Patent Applications | 6 |
| WIPO Patent Applications | 2 |
| Japanese Patent Applications | 1 |
| Clinical Trial Progress | Phase 2 (2021-10-08) |
| Vendors | 1 |
Recent Clinical Trials for ASP8062
| Title | Sponsor | Phase |
|---|---|---|
| Human Laboratory Study of ASP8062 for Alcohol Use Disorder | Astellas Pharma Inc | Phase 2 |
| Human Laboratory Study of ASP8062 for Alcohol Use Disorder | National Institute on Alcohol Abuse and Alcoholism (NIAAA) | Phase 2 |
| A Study to Assess the Safety and Efficacy of ASP8062 as an Add-on Therapy to Buprenorphine/Naloxone in Participants With Opioid Use Disorder | Astellas Pharma Global Development, Inc. | Phase 2 |
Clinical Trial Summary for ASP8062
Top disease conditions for ASP8062
Top clinical trial sponsors for ASP8062
US Patents for ASP8062
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| ASP8062 | ⤷ Start Trial | Sulfur-containing bicyclic compound | Astellas Pharma Inc | ⤷ Start Trial |
| ASP8062 | ⤷ Start Trial | Sulfur-containing bicyclic compound | Astellas Pharma Inc | ⤷ Start Trial |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for ASP8062
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| ASP8062 | Argentina | AR098070 | 2033-10-17 | ⤷ Start Trial |
| ASP8062 | Australia | AU2014335304 | 2033-10-17 | ⤷ Start Trial |
| ASP8062 | Canada | CA2927518 | 2033-10-17 | ⤷ Start Trial |
| ASP8062 | China | CN105636965 | 2033-10-17 | ⤷ Start Trial |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
